Previous 10 | Next 10 |
home / stock / flhlf / flhlf news
FILAMENT HEALTH ANNOUNCES APPOINTMENT OF MICHAEL MESSINGER TO ITS BOARD OF DIRECTORS Canada NewsWire VANCOUVER, BC , March 28, 2024 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage na...
FILAMENT HEALTH ANNOUNCES SHIPMENTS OF BOTANICAL PSILOCYBIN TO FOUR COUNTRIES FOR CLINICAL INVESTIGATION Canada NewsWire Research institutions in the United States , Canada , Israel , and Belgium , including Johns Hopkins University , will study PEX010, Fil...
--News Direct-- Filament Health CEO Ben Lightburn joined Steve Darling from Proactive to share the groundbreaking news that the U.S. Food and Drug Administration (FDA) has given its approval for the Investigational New Drug application for PEX010, Filament Health's botanical psilocybin dr...
FILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO ISRAEL Canada NewsWire Hadassah University Hospital will study PEX010, Filament's botanical psilocybin drug candidate, for the treatment of post-traumatic stress disorder and obsessive-compulsive disorder ...
FILAMENT HEALTH ANNOUNCES FDA OPENING OF INVESTIGATIONAL NEW DRUG APPLICATION FOR SUBSTANCE USE DISORDERS Canada NewsWire The active IND allows initiation of US research with Filament's botanical psilocybin drug candidate for the potential treatment of substance use disorders ...
FILAMENT HEALTH COMPLETES THE FIRST EXPORT OF BOTANICAL PSILOCYBIN TO AUSTRALIA Canada NewsWire Reset Mind Sciences Ltd. has received a shipment of PEX010, Filament's botanical psilocybin drug candidate VANCOUVER, BC , Jan. 17, 2024 /CNW/ - Filament Healt...
FILAMENT HEALTH ANNOUNCES CHANGE TO BOARD OF DIRECTORS Canada NewsWire VANCOUVER, BC , Jan. 2, 2024 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development comp...
2023-12-20 03:50:21 ET More on Filament Health Filament Health raises $14.4M via issuance of senior secured convertible notes Filament Health signs term sheet for a $14.4M convertible note Historical earnings data for Filament Health Financial information for...
FILAMENT HEALTH ANNOUNCES TERMINATION OF PROPOSED BUSINESS COMBINATION WITH JUPITER ACQUISITION CORPORATION Canada NewsWire VANCOUVER, BC , Dec. 19, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (" Filament " or the " Compan...
FILAMENT HEALTH ANNOUNCES TERMINATION OF SHAREHOLDER MEETING AND ENGAGEMENT OF DONOHOE ADVISORY FOR COMPLIANCE EXPERTISE Canada NewsWire VANCOUVER, BC , Dec. 18, 2023 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (" Filament " or t...
News, Short Squeeze, Breakout and More Instantly...
Vancouver, British Columbia--(Newsfile Corp. - June 14, 2024) - Negev Capital Fund One, L.P. (the " Acquiror "), a shareholder of Filament Health Corp. (" Filament "), announces that on June 12, 2024, it was issued 42,284,443 common shares of Filament (the " Common Shares ") from the conversion o...
FILAMENT HEALTH ANNOUNCES CLOSING OF WARRANT EXERCISE, NOTE CONVERSION AND CONCURRENT PRIVATE PLACEMENT OF COMMON SHARES Canada NewsWire VANCOUVER, BC , June 12, 2024 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) (" Filament " ...
FILAMENT HEALTH ANNOUNCES AUTHORIZATION OF PHASE 2 CLINICAL TRIAL FOR PEX010 IN THE TREATMENT OF METHAMPHETAMINE USE DISORDER Canada NewsWire Company study investigating PEX010, Filament's botanical psilocybin drug candidate, has been authorized by both FDA and Health Canada...